About BIOSORTIA PHARMACEUTICALS, INC.
Biosortia is a biotechnology company focused on developing microbiome-derived small molecules for therapeutic applications, particularly in metabolic disease and related conditions. The company utilizes an industrial-scale microbiome mining platform to extract evolutionarily optimized compounds that target the gut-brain-immune axis.
Industrial-Scale Microbiome Mining (ISMM) platformPharmacological geofencing for gut-restricted polypharmacologyBiosortAI for rapid prioritization and optimization of moleculesDevelopment of nature-shaped, evolutionarily informed small moleculesPipeline expansion into obesity/metabolic disease, IBD, CNS, oncology, pain, and anti-infectives
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to BIOSORTIA PHARMACEUTICALS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.